Vertex Pharmaceuticals Incorporated Financial Ratios — VX1

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54
Return on Assets (%)	1.51	-4.31	-17.53	-31.74	-23.02	-4.15	8.18	42.83	16.16	27.02	18.6	21.04	17.71	-2.37	16.41
Return on Capital (%)	3.6	- -	- -	- -	- -	- -	- -	- -	20.84	33.76	23.15	26	22.02	-3.29	20.41
Return on Invested Capital (%)	6.36	- -	- -	- -	- -	- -	- -	- -	17	30.04	22.73	25.79	18.95	2.73	18.17
Gross Margin (%)	94.29	81.67	89.25	89.49	87.94	87.64	88.95	86.56	86.84	88.14	88.06	87.9	87.21	86.11	86.24
EBITDA Margin (%)	10.55	5.56	-46.34	-108.4	-39.19	4.19	7.42	23.22	31.33	47.79	38.39	49.89	40.66	-0.23	36.52
Operating Margin (%)	15.72	3.18	-12.92	-110.52	-45.01	0.66	15.78	21.79	28.87	46.24	36.69	47.59	38.31	-2.12	37.95
Incremental Operating Margin (%)	72.3	- -	65.12	76.78	39.12	71.04	48.52	48.51	48.25	81.62	- -	108.45	- -	- -	487.95
Pretax Margin (%)	4.28	2.1	-51.65	-126.61	-54.03	-3.96	-0.63	19.7	33.51	50.23	36.05	47.39	44.38	2.25	38.69
Profit Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Net Income to Common Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Effective Tax Rate (%)	31.87	- -	- -	- -	- -	- -	- -	- -	15.64	13	14.22	21.51	17.36	315.53	14.86
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,031
ST Debt	- -	14	17	32	87	319	23	5	39	42	80	89	84	87	77
LT Debt	456	683	490	793	739	521	584	582	623	890	887	810	725	1,657	1,953
Total Debt/EBITDA	3.06	8.21	-0.9	-1.31	-2.04	11.79	3.28	0.83	0.51	0.31	0.33	0.2	0.2	-67.87	0.46
Net Debt/EBITDA	-0.51	-1.05	1.01	0.53	1.04	-12.39	-9.02	-3.75	-2.38	-2.02	-2.34	-2.36	-2.58	177.81	-1.16
Total Debt/EBIT	4.01	14.91	-0.83	-1.19	-1.77	84.62	4.92	0.92	0.55	0.33	0.35	0.21	0.21	-7.49	0.49
Net Debt/EBIT	-0.66	-1.91	0.93	0.48	0.9	-88.96	-13.51	-4.17	-2.6	-2.1	-2.44	-2.44	-2.71	19.62	-1.22
EBITDA to Interest Expense	3.95	5.65	-24.5	-8.63	-4.8	0.88	2.66	9.76	22.3	50.96	47.28	81.31	91	-0.84	329.56
EBITDA-CapEx/Interest Expense	1.44	0.92	-26.74	-9.34	-5.34	0.18	-1.08	8.45	21.01	46.49	43.46	77.57	85.15	-16.7	296.65
EBIT to Interest Expense	5.88	3.23	-6.83	-8.8	-5.52	0.14	5.67	9.16	20.55	49.3	45.19	77.55	85.72	-7.63	342.44
Interest Expense	38	15	23	73	84	81	69	72	59	58	62	55	44	31	13
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
Net Debt to Equity	-8.11	-7.48	-41.97	-30.15	-38.37	-66.06	-81.55	-59.75	-51.1	-68.93	-67.28	-75.5	-58.98	-27.85	-27.24
Net Debt/Capital (%)	-8.29	-6.37	-44.01	-25.5	-34.82	-88.84	-169.37	-111.73	-85.48	-164.94	-159.04	-243.8	-129.3	-33.64	-32.57
EBITDA	149	85	-562	-629	-405	71	185	708	1,304	2,966	2,908	4,456	4,013	-26	4,383
EBITDA-CapEx	54	14	-613	-680	-450	15	-75	612	1,229	2,706	2,673	4,251	3,755	-511	3,946
Operating Income (Loss)	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.47	3.05	3.68	3.77	2.06	1.81	2.59	2.83	2.85	3.55	3.51	3.93	3.16	1.72	1.71
Current Ratio	3.39	3.67	3.99	4.2	2.78	2.31	3.28	3.43	3.61	4.33	4.46	4.83	3.99	2.69	2.9
Quick Ratio	2.94	3.39	3.92	4.01	2.43	2.11	3.07	3.19	3.33	4.02	4.04	4.46	3.6	2.17	2.24
CFO/Avg Current Liab	0.33	0.65	-0.15	-1.5	-0.84	0.36	1.06	1.32	1.28	2.03	1.32	1.69	1.12	-0.14	0.98
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
CFO/Total Liabilities	11.27	17.13	-6.3	-46.27	-26.01	15.15	56.19	70.15	70.27	106.15	79.32	97.44	68.69	-8.04	52.05
CFO/CapEx	1.52	3.76	-1.18	-11.19	-8.07	4.17	3.26	13.31	20.81	12.52	11.25	20.18	13.69	-1.01	8.3
Altman's Z-Score	2.21	2.58	9.21	11.01	10.38	5.29	14.94	14.47	16.74	14.22	12.78	13.23	14.62	11.72	12.26

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	14.42	9.36	10.6	7.19	8.27	9.1	10.33	8.82	7.98	8.17	7.49	6.93	6.57	6.95	6.55
Days Sales Outstanding	25.31	39.01	34.45	50.77	44.16	40.12	35.32	41.38	45.73	44.67	48.72	52.7	55.58	52.54	55.69
Inventory Turnover	1.43	3.92	5.84	2.71	2.83	3.12	2.9	3.47	3.75	3.28	2.85	2.66	2.1	1.57	1.14
Days Inventory Outstanding	254.87	93.17	62.49	134.64	129.06	116.9	125.66	105.25	97.23	111.12	127.94	137.46	173.42	231.83	319.64
Accounts Payable Turnover	3.49	2.25	1.51	1.29	2.06	3.39	4.57	4.56	5.95	7	5.58	4.76	4.61	5.13	4.88
Accounts Payable Turnover Days	104.52	162.23	241.21	283.12	176.77	107.82	79.91	79.98	61.33	52.14	65.43	76.65	79.24	71.09	74.85
Cash Conversion Cycle	175.67	-30.05	-144.27	-97.7	-3.55	49.2	81.08	66.65	81.64	103.65	111.24	113.51	149.76	213.29	300.48
Inventory to Cash Days	-229.56	-54.17	-28.05	-83.87	-84.9	-76.78	-90.34	-63.87	-51.5	-66.45	-79.22	-84.76	-117.84	-179.29	-263.95
Inventories	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205	1,687
Raw Materials	32	4	- -	9	9	6	21	10	26	46	42	38	79	252	260
Work In Process	47	11	10	21	41	57	74	88	107	161	224	261	525	769	1,197
Finished Goods	33	15	4	2	8	15	17	27	34	73	87	162	135	185	230
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	6,828	9,056	17,185	28,846	31,644	18,351	38,298	41,572	57,067	60,624	57,088	74,291	105,152	104,303	116,118
- Cash & Cash Equivalents	475	489	569	625	715	1,184	1,665	2,650	3,109	5,988	6,795	10,504	10,369	4,570	5,085
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	142	197	- -	21	154	182	14	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,031
Enterprise Value	6,456	8,628	16,226	28,305	31,582	17,939	36,829	38,990	53,921	54,897	50,531	64,412	94,742	99,932	111,540
Total Capital	1,384	1,893	1,863	1,921	1,920	2,179	2,649	5,022	6,747	9,619	11,067	14,812	18,389	18,154	20,696
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt / EV	0.07	0.08	0.03	0.03	0.03	0.05	0.02	0.02	0.01	0.02	0.02	0.01	0.01	0.02	0.02
EV/Sales	4.58	5.65	13.39	48.77	30.59	10.54	14.8	12.79	12.95	8.85	6.67	7.21	9.6	9.07	9.29
EV/EBITDA	43.37	101.61	- -	- -	- -	251.48	199.47	55.1	41.34	18.51	17.38	14.46	23.61	- -	25.45
EV/EBIT	56.72	184.66	- -	- -	- -	1,805.44	298.84	61.39	45.03	19.22	18.16	14.95	24.72	- -	26.73
EV/Cash Flow to Firm	38.11	- -	- -	- -	- -	- -	- -	- -	33.31	16.61	18.74	15.44	26.51	- -	30.62
EV/Free Cash Flow to Firm	86.3	- -	- -	- -	- -	- -	- -	- -	34.94	18.03	20.53	16.23	28.58	- -	34.8
Diluted Market Cap	6,811	8,833	16,532	28,075	31,002	18,084	38,294	42,225	57,437	61,442	58,305	74,895	106,296	104,693	117,951
Diluted Enterprise Value	6,440	8,406	15,573	27,534	30,940	17,672	36,825	39,644	54,291	55,715	51,747	65,016	95,886	100,321	113,373
EV per Share	30.85	39.71	69.41	117.08	128.22	72.25	145.42	152.8	208.19	211.23	198.57	250.62	367.65	388.93	439.15
TTM Sales	1,411	1,527	1,212	580	1,032	1,702	2,489	3,048	4,163	6,206	7,574	8,931	9,869	11,020	12,001
TTM EBITDA	149	85	-562	-629	-405	71	185	708	1,304	2,966	2,908	4,456	4,013	-26	4,383
TTM Operating Income	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554
TTM Cash Flow to Firm	169	- -	- -	- -	- -	- -	- -	- -	1,619	3,304	2,696	4,173	3,574	-559	3,643
TTM Free Cash Flow to Firm	75	- -	- -	- -	- -	- -	- -	- -	1,543	3,044	2,461	3,968	3,315	-1,044	3,205

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	138.61	44.91	-147.53	-44.97	-75.48	100.72	65.4	35.94	38.45	20.52	24.21	19.08	32.42	-107.05	36.93
EV/EBIT	56.72	184.66	- -	- -	- -	1,805.44	298.84	61.39	45.03	19.22	18.16	14.95	24.72	- -	26.73
Enterprise Value	6,456	8,628	16,226	28,305	31,582	17,939	36,829	38,990	53,921	54,897	50,531	64,412	94,742	99,932	111,540
Low Price	26.52	31.42	41.45	61.44	97.81	71.61	72.12	144.4	161	196.49	175.15	217.16	282.05	383.05	364.53
EV/Sales	4.58	5.65	13.39	48.77	30.59	10.54	14.8	12.79	12.95	8.85	6.67	7.21	9.6	9.07	9.29
EV/EBITDA	43.37	101.61	- -	- -	- -	251.48	199.47	55.1	41.34	18.51	17.38	14.46	23.61	- -	25.45
Price/Earnings	226	- -	- -	- -	- -	- -	142.83	19.76	48.07	22.35	24.68	22.28	29.05	- -	29.57
Price/Earnings Average	304.25	- -	- -	- -	- -	- -	120.69	20.29	40.2	24.11	22.47	21.12	24.06	- -	28.59
Price/Earnings High	409.07	- -	- -	- -	- -	- -	158.87	23.46	49.31	29.62	26.77	24.93	29.55	- -	33.43
Price/Earnings Low	183.73	- -	- -	- -	- -	- -	68.12	17.51	35.12	18.83	19.27	16.74	20.08	- -	23.58
Price/Book Value	8.68	9.06	12.67	26.83	33.67	15.87	18.88	9.37	9.38	6.98	5.65	5.34	5.98	6.36	6.22
Price/Book Value Average	11.68	10.31	11.76	20.08	32.41	18.96	15.95	9.62	7.84	7.53	5.15	5.06	4.95	7.07	6.01
Price/Book Value High	15.71	14.15	15.47	27.65	37.68	26.93	21	11.13	9.62	9.25	6.13	5.97	6.08	8.13	7.03
Price/Book Value Low	7.05	6.83	7.14	13.82	25.63	15.37	9	8.31	6.85	5.88	4.41	4.01	4.13	6	4.96
Price/Tangible Book Value	73.93	29.72	12.97	28.67	52.28	22.33	19.65	9.48	12.19	8.32	6.56	6.08	6.72	7.2	6.77
Price/Tangible Book Value Average	99.53	33.8	12.03	21.45	50.33	26.68	16.6	9.73	10.19	8.98	5.98	5.76	5.56	8	6.54
Price/Tangible Book Value High	133.82	46.4	15.83	29.54	58.52	37.9	21.85	11.26	12.5	11.03	7.12	6.8	6.83	9.21	7.65
Price/Tangible Book Value Low	60.1	22.4	7.31	14.77	39.8	21.63	9.37	8.4	8.9	7.01	5.12	4.57	4.64	6.79	5.4
Price/Sales	4.74	5.78	13.64	48.37	30.03	10.62	15.12	13.59	13.59	9.77	7.63	8.29	10.65	9.5	9.74
Price/Sales Average	6.38	6.58	12.66	36.19	28.91	12.69	12.78	13.96	11.37	10.53	6.95	7.85	8.83	10.57	9.42
Price/Sales High	8.58	9.03	16.65	49.84	33.61	18.03	16.82	16.14	13.94	12.94	8.28	9.27	10.84	12.16	11.01
Price/Sales Low	3.85	4.36	7.69	24.91	22.86	10.29	7.21	12.05	9.93	8.23	5.96	6.23	7.36	8.96	7.77
Price/Cash Flow	46.5	32.98	-272.51	-48.99	-84.84	76.59	44.54	32.61	36.05	18.63	21.87	17.92	29.73	-212.53	32.19
Price/Cash Flow Average	62.6	37.5	-252.87	-36.65	-81.67	91.51	37.64	33.49	30.15	20.09	19.91	16.98	24.62	-236.39	31.12
Price/Cash Flow High	84.17	51.49	-332.65	-50.47	-94.96	130.01	49.54	38.72	36.97	24.69	23.72	20.05	30.23	-271.99	36.39
Price/Cash Flow Low	37.8	24.86	-153.66	-25.23	-64.59	74.21	21.24	28.91	26.34	15.69	17.07	13.47	20.55	-200.54	25.67
Price/Free Cash Flow Average	186.6	51.06	-136.9	-33.65	-72.66	120.34	55.27	36.9	32.16	22.13	22.04	18.08	26.85	-119.06	35.7
Price/Free Cash Flow High	250.9	70.11	-180.09	-46.34	-84.49	170.97	72.74	42.67	39.44	27.19	26.25	21.34	32.97	-137	41.75
Price/Free Cash Flow Low	112.69	33.85	-83.19	-23.16	-57.47	97.59	31.19	31.86	28.09	17.29	18.9	14.33	22.41	-101.01	29.45
EV/Sales Average	6.25	6.46	12.37	36.25	29.45	12.64	12.41	13.16	10.71	9.61	6	6.78	7.77	10.13	8.97
EV/Sales High	8.5	8.98	16.52	50.28	34.25	18.06	16.53	15.35	13.31	12.02	7.31	8.2	9.78	11.72	10.56
EV/Sales Low	3.67	4.19	7.2	24.66	23.28	10.2	6.75	11.24	9.26	7.31	5.02	5.14	6.31	8.53	7.33
EV/EBITDA Average	59.25	116.23	- -	- -	- -	301.57	167.32	56.68	34.18	20.11	15.62	13.58	19.11	- -	24.57
EV/EBITDA High	80.53	161.45	- -	- -	- -	430.91	222.75	66.11	42.46	25.15	19.04	16.43	24.05	- -	28.9
EV/EBITDA Low	34.79	75.35	- -	- -	- -	243.47	90.97	48.43	29.55	15.29	13.07	10.31	15.52	- -	20.08
EV/EBIT Average	77.49	211.23	- -	- -	- -	2,165.09	250.68	63.14	37.23	20.89	16.32	14.05	20.01	- -	25.8
EV/EBIT High	105.32	293.41	- -	- -	- -	3,093.62	333.73	73.64	46.25	26.12	19.9	17	25.19	- -	30.36
EV/EBIT Low	45.5	136.94	- -	- -	- -	1,747.94	136.29	53.95	32.19	15.87	13.66	10.66	16.25	- -	21.09
Last Price	32.62	41.68	73.51	119.31	128.47	73.91	151.22	162.92	220.34	233.27	224.33	289.06	408.05	405.94	457.17
High Price	59.05	65.06	89.73	122.94	143.8	125.45	168.2	193.42	226.01	309.09	243.28	323.35	415.02	519.51	516.81
Enterprise Value Average	8,820	9,870	14,988	21,042	30,399	21,512	30,894	40,103	44,582	59,654	45,416	60,515	76,689	111,639	107,679
Enterprise Value High	11,987	13,710	20,019	29,181	35,357	30,738	41,129	46,774	55,389	74,602	55,352	73,226	96,538	129,112	126,687
Enterprise Value Low	5,179	6,399	8,732	14,314	24,029	17,367	16,797	34,265	38,551	45,338	38,015	45,933	62,273	94,049	88,010

Shares Outstanding	209	217	234	242	246	248	253	255	259	260	254	257	258	257	254
Diluted Weighted Avg Shares	209	212	225	235	241	245	253	259	261	263	260	259	261	258	258
Basic Weighted Avg Shares	205	212	225	235	241	245	249	254	257	260	258	256	258	258	256
Revenue per Share	6.88	7.2	5.39	2.47	4.28	6.96	10	11.98	16.21	23.88	29.39	34.87	38.3	42.73	46.94
EBITDA per Share	0.73	0.4	-2.5	-2.67	-1.68	0.29	0.74	2.78	5.08	11.41	11.28	17.4	15.57	-0.1	17.14
Operating Income per Share	1.08	0.23	-0.7	-2.73	-1.93	0.05	1.58	2.61	4.68	11.04	10.78	16.59	14.67	-0.91	17.81
Basic EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.06	8.25	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Basic EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.37	8.21	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Diluted EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.04	8.09	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Diluted EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.36	8.05	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.7	1.26	-0.27	-2.44	-1.51	0.96	3.4	5	6.11	12.52	10.26	16.13	13.73	-1.91	14.2
Free Cash Flow per Basic Share	0.24	0.93	-0.5	-2.65	-1.7	0.73	2.35	4.62	5.82	11.52	9.35	15.33	12.72	-3.79	12.49
Cash & Equivalents per Share	4.63	6.08	6.27	5.74	4.23	5.78	8.25	12.42	14.7	25.62	29.57	41.94	43.53	23.8	26.02
Book Value per Share	3.76	4.6	5.8	4.45	3.82	4.66	8.01	17.38	23.5	33.42	39.69	54.13	68.22	63.87	73.49
Tangible Book Value per Share	0.44	1.4	5.67	4.16	2.46	3.31	7.7	17.18	18.08	28.03	34.18	47.55	60.74	56.42	67.54

Vertex Pharmaceuticals Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)